DID YOU KNOW? DTIC has over 3.5 million final reports on DoD funded research, development, test, and evaluation activities available to our registered users. Click HERE
to register or log in.
Treatment Options and Survival of Metastatic Prostate Cancer Patients
In this proposal, we will utilize a prostate cancer cohort from the VA hospitals to explorethe survival benefit among men diagnosed with metastatic prostate cancer who receivedefinitive treatment (alone or with adjuvant therapies) compared to men who receive nondefinitive treatment; and we will assess the treatment related side effects that affect quality of life among men diagnosed with metastatic prostate cancer who receive definitivevs. non-definitive treatment. The specific aims are:Aim 1: To examine the survival benefit among men diagnosed with metastatic prostatecancer that receive definitive treatment compared to men that receive non-definitivetreatment.
Approved For Public Release